Reaction Details Report a problem with these data
Target
Galectin-3
Ligand
BDBM632626
Substrate
n/a
Meas. Tech.
Biological Assay
IC50
33.8±n/a nM
Citation
 BOLLI, M; GATFIELD, J; GRISOSTOMI, C; REMEN, L; SAGER, C; ZUMBRUNN, C GALECTIN-3 INHIBITING 2-HYDROXYCYCLOALKANE-1-CARBAMOYL DERIVATIVES US Patent  US20230348442 Publication Date 11/2/2023 
Target
Name:
Galectin-3
Synonyms:
LEG3_HUMAN | LGALS3 | MAC2
Type:
Enzyme
Mol. Mass.:
26156.54
Organism:
Homo sapiens (Human)
Description:
P17931
Residue:
250
Sequence:
MADNFSLHDALSGSGNPNPQGWPGAWGNQPAGAGGYPGASYPGAYPGQAPPGAYPGQAPPGAYPGAPGAYPGAPAPGVYPGPPSGPGAYPSSGQPSATGAYPATGPYGAPAGPLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI
  
Inhibitor
Name:
BDBM632626
Synonyms:
(2R,3R,4S,5R,6R)-N-(3-chloro-5-cyanophenyl)-3,5-dihydroxy-N-((1S,2S)-2- hydroxycyclobutyl)-6-(hydroxymethyl)-4-(4-(3,4,5-trifluorophenyl)-1H-1,2,3- triazol-1-yl)tetrahydro-2H-pyran-2-carboxamide | US20230348442, Example 2H.1.4
Type:
Small organic molecule
Emp. Form.:
C26H23ClF3N5O6
Mol. Mass.:
593.939
SMILES:
OC[C@H]1O[C@H]([C@H](O)[C@H]([C@H]1O)n1cc(nn1)-c1cc(F)c(F)c(F)c1)C(=O)N([C@H]1CC[C@@H]1O)c1cc(Cl)cc(c1)C#N
Structure:
Search PDB for entries with ligand similarity: